Citas bibligráficas
Esta es una referencia generada automáticamente. Modifíquela de ser necesario
Galindo, B., (2022). Copeptin and metabolic syndrome: a systematic review [Universidad Peruana Unión]. http://repositorio.upeu.edu.pe/handle/20.500.12840/5438
Galindo, B., Copeptin and metabolic syndrome: a systematic review []. PE: Universidad Peruana Unión; 2022. http://repositorio.upeu.edu.pe/handle/20.500.12840/5438
@misc{renati/940279,
title = "Copeptin and metabolic syndrome: a systematic review",
author = "Galindo Yllu, Brenda Mireya",
publisher = "Universidad Peruana Unión",
year = "2022"
}
Título: Copeptin and metabolic syndrome: a systematic review
Autor(es): Galindo Yllu, Brenda Mireya
Asesor(es): Huancahuire Vega, Salomón
Palabras clave: Copeptin; Metabolic syndrome; Biomarker; Systematic review
Campo OCDE: http://purl.org/pe-repo/ocde/ford#3.00.00
Fecha de publicación: 6-abr-2022
Institución: Universidad Peruana Unión
Resumen: Background: Copeptin, a reliable marker for vasopressin release, has been associated with cardiometabolic diseases including metabolic syndrome (MetS). This systematic review aims to evaluate the association between copeptin and MetS. Methods: We searched in Pubmed, Scopus, EMBASE, and Web of Science databases until March 2021 and included observational studies (cohort studies, cross-sectional, and case-control) reporting the risk or prevalence of having MetS in patients with elevated copeptin levels compared to patients without elevated copeptin levels. Risk of bias was evaluated with the New Castle-Ottawa Scale. Meta-analysis was not performed because of the heterogeneity of the copeptin cut-off values. Results: A total of 7 studies (5 cross-sectional, 1 case-control, 1 cohort) were included comprising 11 699 participants. Most of them were performed in the adult general population. Two cross-sectional and the case-control studies found a positive significant association between higher levels of copeptin and the MetS. While three cross-sectional and the cohort study found no association. The case-control study had several methodological limitations, most cross-sectional studies where methodologically adequate and the cohort study had no methodological issues. Conclusions: The association between copeptin and MetS is inconsistent. However, this biomarker could be important for the early detection of MetS and implementation of preventive interventions. Thus, future studies should corroborate this association.
Enlace al repositorio: http://repositorio.upeu.edu.pe/handle/20.500.12840/5438
Disciplina académico-profesional: Medicina Humana
Institución que otorga el grado o título: Universidad Peruana Unión. Facultad de Ciencias de la Salud
Grado o título: Médico Cirujano
Jurado: Marcos Carbajal, Pool; Concha Toledo, Manuel Daniel; Segura Chávez, Luis Felipe; Huancahuire Vega, Salomón
Fecha de registro: 9-may-2022
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons